Breakthrough gene therapy jab reverses hearing loss in weeks

A single jab of a breakthrough gene therapy could reverse hearing loss in people within weeks, according to new research.

The cutting-edge therapy improved hearing in children and adults with congenital deafness or severe hearing impairment, with a 7-year-old regaining almost full hearing in a clinical trial, researchers from Sweden’s Karolinska Institutet said.

The clinical trial, detailed in the journal Nature Medicine, showed that a healthy copy of the OTOF gene injected in the inner ear improved hearing of all 10 participants.

The small-scale trial included people who had a genetic form of deafness or severe hearing impairment caused by mutations in a gene called OTOF.

These mutations cause a deficiency of the protein otoferlin, which plays a key role in transmitting sound signals from the ear to the brain.

While the therapy seemed to work best in children, researchers said, it could benefit adults as well.

Representational. A single jab of a breakthrough gene therapy could reverse hearing loss within weeks
Representational. A single jab of a breakthrough gene therapy could reverse hearing loss within weeks (AFP via Getty)

In the trial, a synthetic, harmless version of the adeno-associated virus was used to deliver a properly functional OTOF gene to the inner ear via a single injection.

The effects of the therapy were evident in the majority of patients, whose hearing recovered rapidly after just a month.

After six months, researchers noted considerable hearing improvement in all participants, with their average volume of perceptible sound improving from 106 decibels to 52.

Those between the ages of five and eight responded best to the treatment, the study found.

One seven-year-old girl quickly recovered almost all her hearing, and she was able to hold daily conversations with her mother four months afterwards.

“This is the first time that the method has been tested in teenagers and adults,” Maoli Duan, an author of the study from Karolinska Institutet, said.

“Hearing was greatly improved in many of the participants, which can have a profound effect on their life quality. We will now be following these patients to see how lasting the effect is.”

Researchers also found that the treatment was safe and well-tolerated. Participants did not report any serious adverse reactions in the follow-up period of 6-12 months.

The most common reaction was a reduction in the number of the immune system’s neutrophils, a type of white blood cell.

“OTOF is just the beginning,” Dr Duan said, adding that researchers were working on other common genes behind deafness such as GJB2 and TMC1.

“These are more complicated to treat, but animal studies have so far returned promising results. We are confident that patients with different kinds of genetic deafness will one day be able to receive treatment.”

Source link

Visited 1 times, 1 visit(s) today

Related Article

A couple watching TV.

2 Stocks to Buy With $5,000 and Hold for a Decade

Streaming giants Netflix (NFLX 0.92%) and Roku (ROKU 2.05%) have a lot in common. The former was an early investor in the latter. They both dominate their respective niches in the streaming industry and have produced market-beating returns over the long term. Here’s one more thing Netflix and Roku have in common: excellent long-term prospects

Fire erupts after Israeli strikes in Gaza

Gaza ceasefire talks set to resume in Doha as Israeli airstrikes continue in the Strip

Indirect negotiations between Israel and Hamas for a possible ceasefire in Gaza are set to resume Sunday in Doha amid the backdrop of continued deadly Israeli attacks in the Strip. Israeli airstrikes killed at least 38 Palestinians in Gaza, hospital officials told the Associated Press on Sunday, as Israel’s military said it has struck over

A gold bull figurine sitting on stacks of hundred dollar bills.

The S&P 500 Is Soaring: 3 No-Brainer Vanguard ETFs to Buy Right Now

The S&P 500 (^GSPC 0.83%) reached a new all-time high in late June, soaring by more than 26% from its low point in April, as of this writing. Many investors are optimistic that the market will continue climbing, making right now a fantastic opportunity to load up on quality stocks. ETFs are a simple way to

White House suggests some countries could see tariff deadline shifted

White House suggests some countries could see tariff deadline shifted

Chair of the White House Council of Economic Advisers Stephen Miran said that some countries that are negotiating with the United States in good faith could see tariffs delayed as President Donald Trump’s deadline to strike trade deals closes in. Speaking with ABC News’ “This Week” anchor George Stephanopoulos, Miran hedged on what deals are

Happy person sitting with phone and laptop.

What Are 5 Great Growth Stocks to Buy That Are Down 20% or More?

While the market has returned to new highs, not every growth stock has rebounded at the same pace. Five stocks still down 20% or more from all-time highs that look attractive are Advanced Micro Devices (AMD -0.45%), GitLab (GTLB 2.73%), e.l.f. Beauty (ELF 1.21%), Dutch Bros (BROS 1.74%), and Cava Group (CAVA 4.96%). Let’s look

Today's Wordle answer for Sunday, July 6 - ATRIA

Clues and answer for Sunday, July 6

Hey, there! Sunday is upon us and that just about brings the weekend to an end. When it comes to your Wordle streak though, we hope that doesn’t peter out for a very long time. To that end, here’s our daily Wordle guide with some hints and the answer for Sunday’s puzzle (#1,478). It may

0
Would love your thoughts, please comment.x
()
x